NCT06630104
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD) No drug interventions supportive_care Not Available not_yet_recruiting NCT00001379
Treatment and Natural History Study of Lymphomatoid Granulomatosis treatment 2 active_not_recruiting NCT00092222
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity treatment 2 active_not_recruiting NCT03258567
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas treatment 2 recruiting NCT00935090
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer No drug interventions diagnostic Not Available recruiting NCT01273090
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma treatment 1 completed NCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer No drug interventions Not Available Not Available recruiting NCT00899951
Studying Fentanyl in Patients With Cancer Not Available Not Available terminated NCT01000753
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma No drug interventions Not Available Not Available completed NCT02057445
3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma No drug interventions treatment 1 completed NCT00324597
AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma treatment 1 unknown_status NCT00750009
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial No drug interventions other 3 completed NCT00952185
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers No drug interventions supportive_care Not Available terminated NCT00278200
Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD No drug interventions treatment 1 terminated NCT00956475
Quality of Life in Younger Leukemia and Lymphoma Survivors No drug interventions Not Available Not Available completed NCT00033475
Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation treatment 3 unknown_status NCT00661999
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer supportive_care 3 completed NCT01118013
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant treatment 2 terminated NCT00436618
Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment treatment 2 completed NCT02861417
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant treatment 2 active_not_recruiting NCT00376922
Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases No drug interventions supportive_care Not Available completed NCT01137825
Registry of Older Patients With Cancer No drug interventions Not Available Not Available recruiting NCT00387530
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer treatment 2 withdrawn NCT00900120
Collecting and Storing Blood Samples From Patients With Cancer No drug interventions Not Available Not Available withdrawn NCT00058331
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors supportive_care 3 completed NCT00066469
Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation treatment 2 completed NCT00516503
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer supportive_care 3 completed NCT00734890
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma treatment 1 completed NCT00065390
Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome treatment 1 completed NCT00053053
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer No drug interventions supportive_care 3 completed NCT00666211
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain No drug interventions supportive_care 3 completed NCT00087009
Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation treatment 1 terminated NCT01447056
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases No drug interventions treatment 1 completed NCT04883437
Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas treatment 2 recruiting NCT01116232
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation supportive_care 2 terminated NCT00424242
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases treatment 0 completed NCT00255749
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer supportive_care 2 completed NCT00621036
Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma treatment 2 withdrawn NCT00823524
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer treatment 1 / 2 completed NCT00416624
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy supportive_care 2 completed NCT00719563
American Ginseng in Treating Patients With Fatigue Caused by Cancer supportive_care 3 completed NCT00646139
KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment treatment 1 completed NCT00726830
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer supportive_care Not Available terminated NCT00070382
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer supportive_care 3 completed NCT00993694
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone Not Available Not Available completed NCT01147991
Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer treatment 1 completed NCT00013689
Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome treatment 1 completed NCT02402244
Project: Every Child for Younger Patients With Cancer No drug interventions Not Available Not Available recruiting NCT00093704
Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma treatment 1 terminated NCT00499668
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer supportive_care Not Available withdrawn NCT01101412
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies supportive_care 1 / 2 withdrawn NCT00869323
Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders treatment 2 terminated NCT03394365
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy treatment 3 recruiting NCT05898789
Virtual Rehabilitation for Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT02579967
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies No drug interventions treatment 2 recruiting NCT03663933
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation No drug interventions treatment 2 recruiting NCT03922724
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma No drug interventions treatment 2 recruiting NCT04339777
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity treatment 2 recruiting NCT05770102
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition treatment 2 / 3 recruiting NCT01728402
Pathogenesis of Hematologic Malignancies No drug interventions Not Available Not Available enrolling_by_invitation NCT04309084
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma treatment 1 active_not_recruiting NCT02690545
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL No drug interventions treatment 1 / 2 recruiting NCT00579111
Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) treatment 1 / 2 terminated NCT04858256
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms treatment 2 recruiting NCT00992732
Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders treatment 2 terminated NCT04734470
Expression of CD19 Complex in Lymphoproliferative Disorders No drug interventions Not Available Not Available unknown_status NCT00028418
Clofarabine in Chronic Lymphocytic Leukemia treatment 1 completed NCT03601819
Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders treatment 1 terminated NCT05803616
Liquid Biopsy to Enable Diagnostics and Monitoring for Immune-mediated Lymphoproliferative Disorders No drug interventions Not Available Not Available recruiting NCT05001386
In Vitro Drug Sensitivity Testing of Fresh Human Samples No drug interventions other Not Available not_yet_recruiting NCT05718986
Familial B-cell Lymphoproliferative Disorders No drug interventions Not Available Not Available not_yet_recruiting NCT00063648
Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant No drug interventions prevention 1 completed NCT03744676
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007) treatment 2 completed NCT02505789
Transfusion-related EBV Infection Among Allogeneic Stem Cell Transplant Pediatric Recipients No drug interventions Not Available Not Available unknown_status NCT00048412
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H treatment 1 / 2 completed NCT00131014
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies No drug interventions Not Available Not Available recruiting NCT05969821
Clonal Hematopoiesis of Immunological Significance No drug interventions Not Available Not Available not_yet_recruiting NCT05431179
A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma treatment 3 withdrawn NCT00002153
Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders treatment 1 completed NCT02663297
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas No drug interventions treatment 1 active_not_recruiting NCT00968461
Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders treatment 1 withdrawn NCT03939585
Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT No drug interventions treatment 1 not_yet_recruiting NCT05155215
Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma treatment 1 / 2 unknown_status NCT05770037
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Teenage/Young Adults (TYA) and Paediatric Patients With ALK Positive Cancers treatment 2 / 3 recruiting NCT06271252
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study treatment 1 recruiting NCT06042400
Trial of Written Exposure for Metastatic Cancer Patients (EASE) No drug interventions supportive_care Not Available completed NCT00123942
Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease treatment 1 terminated NCT03397706
Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV-Associated Lymphoid Malignancies treatment 1 / 2 completed NCT02973113
Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE) treatment 1 completed NCT03373019
Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) treatment 2 unknown_status NCT01186224
Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC) treatment Not Available unknown_status NCT03602157
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL treatment 1 recruiting NCT05770544
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. treatment 2 / 3 recruiting NCT00058604
Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs). No drug interventions treatment 1 completed NCT00068146
Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma No drug interventions Not Available Not Available completed NCT02822495
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies Not Available Not Available no_longer_available NCT04554914
A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases treatment 2 recruiting NCT03340155
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases No drug interventions other Not Available unknown_status NCT00001438
A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes treatment 2 completed NCT03392142
Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab treatment 3 completed NCT00917826
Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies treatment 2 terminated NCT00354120
Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant No drug interventions treatment 2 / 3 completed NCT06644339
Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence No drug interventions treatment Not Available not_yet_recruiting NCT01800643
Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation No drug interventions treatment 2 / 3 unknown_status NCT00359411
Genetic Studies of X-linked Lymphoproliferative Disease No drug interventions Not Available Not Available completed NCT01555892
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE No drug interventions treatment 1 recruiting NCT00516152
Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT treatment 2 completed